Neuroone Medical Technologies (NMTC) Other Non-Current Assets (2015 - 2016)
Neuroone Medical Technologies (NMTC) posted Other Non-Current Assets of $4277.0 for Q4 2016, little changed on a QoQ basis from $4277.0 in Q3 2016, and up 132.7% year-over-year from $1838.0 in Q1 2016.
Neuroone Medical Technologies (NMTC) Other Non-Current Assets (2015 - 2016) Analysis & Trends
Neuroone Medical Technologies' Other Non-Current Assets history runs 2 years deep, the most recent figure standing at $4277.0 for Q4 2016.
- Quarterly Other Non-Current Assets rose 132.7% year-over-year to $4277.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $4277.0 (up 132.7% YoY) and the FY2016 annual result came in at $4277.0, up 132.7% from the prior year.
- Other Non-Current Assets was $4277.0 for Q4 2016 at Neuroone Medical Technologies, roughly flat from $4277.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4277.0 in Q2 2016 and bottomed at $1838.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 4,277.00 |
| Sep 30, 2016 | 4,277.00 |
| Jun 30, 2016 | 4,277.00 |
| Dec 31, 2015 | 1,838.00 |